Back to Market Feed

MOUNJARO 2.5 MG/0.5 ML PEN

tirzepatide
$538.7950per ML

Strength

2.5 mg/.5mL

NDC

00002150680

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

TIRZEPATIDE

Approval Type

New Drug (NDA)

FDA Application

NDA215866

On Market Since

5/13/2022

Pharmacological Classes

G-Protein-linked Receptor Interactions
GLP-1 Receptor Agonist
Glucagon-like Peptide-1 (GLP-1) Agonists
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+3.4%

3Y

+9.8%

5Y

N/A

All

+15.3%

Generic Alternatives

Save up to 2%

1 alternative • Same active ingredient

ZEPBOUND 2.5 MG/0.5 ML PEN
Brand
00002250680•Eli Lilly and Company
$526.3087
Save 2%

Related Drugs

Same classification

RYBELSUS 3 MG TABLET
Brand
00169430330•Novo Nordisk
$33.1602
per EA
RYBELSUS 14 MG TABLET
Brand
00169431430•Novo Nordisk
$33.1671
per EA
RYBELSUS 7 MG TABLET
Brand
00169430730•Novo Nordisk
$33.1730
per EA
SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0731
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8558
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1538
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7373
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8351
per ML
OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN
Brand
00169477212•Novo Nordisk
$331.9569
per ML
OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN
Brand
00169413013•Novo Nordisk
$331.9930
per ML